supranuclear


Also found in: Encyclopedia.

su·pra·nu·cle·ar

(sū'pră-nū'klē-ăr),
1. Above (cranial to) the level of the motor neurons of the spinal or cranial nerves; those pathways the suprasegmental nerve fibers follow to reach the motor cell bodies in the brainstem. As used in clinical neurology, supranuclear indicates disorders of movement caused by destruction or functional impairment of brain structures other than the motor neurons, such as the motor cortex, pyramidal tract, or striate body, for example, supranuclear palsy, as distinguished from the nuclear (or flaccid, or "lower motor neuron") paralysis that results from destruction or functional impairment of the motor neurons or their axons in a peripheral nerve.
2. Region of the cytoplasm apical to the nucleus.

su·pra·nu·cle·ar

(sū'pră-nū'klē-ăr)
Above (cranial to) the level of the motor neurons of the spinal or cranial nerves; the pathways the suprasegmental nerve fibers follow to reach the motor cell bodies in the brainstem; as used in clinical neurology, supranuclear indicates disorders of movement caused by destruction or functional impairment of brain structures other than the motor neurons, such as the motor cortex, pyramidal tract, or striate body, e.g., supranuclear palsy, as distinguished from the nuclear (or flaccid, or "lower motor neuron") paralysis that results from destruction or functional impairment of the motor neurons or their axons in a peripheral nerve.

supranuclear 

In general, referring to nerve fibres situated above a nucleus, such as the abducens, oculomotor and trochlear cranial nerve nuclei.

su·pra·nu·cle·ar

(sū'pră-nū'klē-ăr)
Above (i.e., cranial to) level of motor neurons of spinal or cranial nerves.
References in periodicals archive ?
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.
US-based biopharmaceutical company AbbVie (NYSE: ABBV) has started two Phase 2 clinical trial programmes to evaluate ABBV-8E12, an investigational anti-tau antibody, in patients with early Alzheimer's disease and progressive supranuclear palsy, the company said.
Biopharmaceutical company AbbVie (NYSE:ABBV) reported on Wednesday the launch of two Phase 2 clinical trial programmes to evaluate ABBV-8E12 in patients with early Alzheimer's disease and progressive supranuclear palsy (PSP).
In our case, vertical supranuclear palsy, prominent postural instability, symmetric rigidity, dementia, and early dysathria are the main characteristics of PSP.
Keywords: caregiver strain, nurse case management, progressive supranuclear palsy (PSP), telehealth
Brown was told he is suffering from the neurological condition Progressive Supranuclear Palsy (PSP).
Karen said: "My mother suffers from progressive supranuclear palsy, which is a degenerative disease.
There is a need to characterize disease progression in idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) to test the effectiveness of disease-modifying interventions.
Her dad, Bob Burke, has battled Progressive Supranuclear Palsy (PSP) - for which there is no cure and the life expectancy is around seven years - since 2011.
10) have showed that the anteroposterior diameter of the inferior portion of the pons in MSA-C patients is lower when compared to patients in the control group or with progressive supranuclear palsy.
USPRwire, Mon Sep 07 2015] Global Markets Direct's, 'Progressive Supranuclear Palsy - Pipeline Review, H2 2015', provides an overview of the Progressive Supranuclear Palsy's therapeutic pipeline.
A support group for people with Parkinson's plus (multiple system atrophy, progressive supranuclear palsy or other atypical Parkinson's diseases) and their partners.